findmyKOL

Justin Tannir, MD

Basic profile

Wayne State University

ORCIDNone on fileNPI
RegionTraverse City, MI · MidwestSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Justin Tannir is an Ophthalmology physician affiliated with Wayne State University. OpenAlex indexes 40 publications with 406 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
40publications

Distinct works indexed by OpenAlex.

406citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
32companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5199 N Royal Dr
Traverse City, MI 496849201

Telephone

231-935-8101

Provider last certified this registry record 28 May 2020.

View the NPPES registry record

Industry payments

32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    85.5%
    Prostaglandin Analog32.2%
    Latanoprost46%Bimatoprost23%Lumigan20%Travoprost9%Tafluprost3%
    Part D<11 patients
    alpha-Adrenergic Agonist18.8%
    Brimonidine Tartrate66%Brimonidine Tartrate-Timolol23%Combigan12%
    Part D109 patients

    + 6 more classes in this area

  • Cardiovascular

    4.5%
    Beta blocker4.5%
    Timolol Maleate100%
    Part D43 patients
  • Musculoskeletal

    4.4%
    Cyclooxygenase Inhibitor4.4%
    Ketorolac Tromethamine100%
    Part D68 patients
Where care is delivered (Part B)6.6% facility · 93.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

35 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”